For Crohn’s Disease and Ulcerative Colitis, Company Reveals Results of New Study and Is Recruiting for Clinical Trial
Crohn's Disease, IBD News, News, Ulcerative colitis
Immune Pharmaceuticals recently published new data on the impact of eotaxin-1 in ulcerative colitis (UC) and Crohn’s disease (CD). The article, “The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New ... Read more